研究者氏名	吉川哲史
	ヨシカワ
URL
所属	藤田医科大学
部署	医学部医学科小児科学
職名	教授
学位	臓器移植後のhuman herpesvirus 6(藤田保健衛生大学)
J-Global ID	200901031230982717

プロフィール

小児のウイルス感染症、特にヘルペスウイルスとロタウイルス感染を研究しています。

研究分野

ライフサイエンス / 胎児医学、小児成育学 /

論文

12 3 4 5 >

Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

Takako Suzuki Yoshitaka Sato Yusuke Okuno Yuka Torii Yuto Fukuda Kazunori Haruta Makoto Yamaguchi Yoshiki Kawamura Asahito Hama Atsushi Narita Hideki Muramatsu Tetsushi Yoshikawa Yoshiyuki Takahashi Hiroshi Kimura Yoshinori Ito Jun-ichi Kawada

Journal of Clinical Immunology 44(4) 2024年4月

Analysis of cytokine profiles in pediatric fulminant myocarditis and acute myocarditis multicenter study

Yoji Nomura Takanori Suzuki Katsuyuki Kunida Hidetoshi Uchida Ryoichi Ito Yasunori Oshima Machiko Kito Yuki Imai Satoru Kawai Kei Kozawa Kazuyoshi Saito Tadayoshi Hata Junichiro Yoshimoto Tetsushi Yoshikawa Kazushi Yasuda

Pediatric Cardiology 2024年3月 [査読有り]

Assessment of patients' characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease.

Yasumasa Kakei Ichiro Morioka Takumi Imai Kotaro Itohara Ikuko Yano Naoto Takahashi Tetsushi Yoshikawa Hiroyuki Moriuchi Yoshinori Ito Kazumichi Fujioka Akira Oka

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024年3月

INTRODUCTION: Insurance coverage for oral valganciclovir (VGCV) began in Japan in April 2023 on the basis of results, including our clinical trials for symptomatic congenital cytomegalovirus (CMV) disease. The VGCV treatment is available throughou...

A GIRL WITH ADENOVIRUS TYPE 2 INDUCED INTERSTITIAL PNEUMONITIS ACUTELY EXACERBATED WITH PRIMARY HUMAN HERPESVIRUS 7 INFECTION.

Yoshiki Kawamura Kei Kozawa Goro Koinuma Tetsuo Onda Kazutoshi Cho Yuki Higashimoto Hiroki Miura Tetsushi Yoshikawa

The Pediatric infectious disease journal 2024年2月

We encountered a previously healthy 3-year-old girl with interstitial pneumonitis that initially developed due to human adenovirus type 2 infection and exacerbated by primary human herpesvirus 7 infection. A comprehensive serum biomarker analysis ...

Development of recombinant rotavirus carrying herpes simplex virus 2 glycoprotein D gene based on reverse genetics technology.

Yoshiki Kawamura Satoshi Komoto Saori Fukuda Masanori Kugita Shuang Tang Amita Patel Julianna R Pieknik Shizuko Nagao Koki Taniguchi Philip R Krause Tetsushi Yoshikawa

Microbiology and immunology 68(2) 56-64 2024年2月

Vaccine development for herpes simplex virus 2 (HSV-2) has been attempted, but no vaccines are yet available. A plasmid-based reverse genetics system for Rotavirus (RV), which can cause gastroenteritis, allows the generation of recombinant RV cont...